Miki Yoneyama, Konstantinos Zormpas-Petridis, Ruth Robinson, Faranak Sobhani, Elena Provenzano, Harriet Steel, Sara Lightowlers, Catherine Towns, Simon P Castillo, Selvakumar Anbalagan, Tom Lund, Erik Wennerberg, Alan Melcher, Charlotte E Coles, Ioannis Roxanis, Yinyin Yuan, Navita Somaiah
BACKGROUND: Tumor-infiltrating lymphocytes (TILs) have prognostic significance in several cancers, including breast. Despite interest in combining radiotherapy with immunotherapy, little is known about the effect of radiotherapy itself on the tumor-immune microenvironment, including TILs. Here, we interrogated longitudinal dynamics of tumor-infiltrating and systemic lymphocytes in patient samples taken before, during, and after neoadjuvant radiotherapy (NART), from XXX and XXX breast clinical trials...
April 26, 2024: International Journal of Radiation Oncology, Biology, Physics